PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs BAX |
|---|---|---|---|---|---|
| RMD | ResMed Inc. | 0.81 | 21.2 | 26.1% | — |
| ALC | Alcon Inc. | 1.34 | 55.8 | 41.7% | — |
| MMSI | Merit Medical Systems, Inc. | 1.42 | 26.1 | 18.3% | — |
| BDX | Becton, Dickinson and Company | 3.37 | 54.8 | 16.3% | — |
| WST | West Pharmaceutical Services, Inc. | 5.64 | 44.3 | 7.9% | — |